Growth Strategies Case Study

GlaxoSmithkline Plc: Scouting for Growth Avenues

OR

Abstract:

In the year 2000, GlaxoWellcome plc and SmithklineBeecham plc. merged to form GlaxoSmithkline plc (GSK). In recent years, GSK has been facing challenges on many fronts: patent expiration, lack of promising drugs and ongoing lawsuits. With increasing pressure on the profit margins, GSK is revamping its strategy to sustain its leadership in the global pharmaceutical industry.

Pedagogical Objectives:

• To highlight growth strategies of GSK with respect to new drug development
• To discuss the strategies adopted by GSK to deal with the competition it is facing from the generic drug makers.

Keywords : Pharmaceutical industry; Centres of Excellence for Drug Discovery; Patents; Generics; Growth Strategies Case Study; Clinical trials; Paxil; Dr Jean Pierre Garnier; New product pipeline; Patent expiry; Blockbuster drugs

Contents : 
Introduction
GSK-AnOverview
GSK - Challenges
Patent Expiration and Generics
GSK- Revamping its Strategy
Top Ten Global Pharmaceutical Companies
GSK Key Drugs
World Wide Locations (R&D At GSK)
What it Takes to Make a Medicine